Which is a common contributing factor to Type F ADRs?

Get ready for Drug Action 2 Exam 1. Study with flashcards, multiple choice questions, and detailed explanations. Boost your confidence and ace your exam with ease!

Multiple Choice

Which is a common contributing factor to Type F ADRs?

Explanation:
Type F adverse drug reactions reflect a failure of therapy due to interactions between drugs that blunt or negate the intended effect. The most common contributing factor is drug interactions themselves, because when another drug or substance alters the pharmacokinetics or pharmacodynamics of the primary drug, it can drive down its levels or diminish its action, leading to subtherapeutic response or treatment failure. For example, enzyme-inducing drugs or substances can speed up metabolism and reduce drug exposure, while enzyme inhibitors can sometimes raise levels and increase toxicity, but the hallmark for Type F is the loss of efficacy from interactions with other agents. Genetic predisposition often affects whether someone experiences a particular adverse effect, but it doesn’t routinely explain therapeutic failure across patients. Dietary factors and environmental exposures can influence absorption or exposure, but they’re not the common driver of Type F ADRs.

Type F adverse drug reactions reflect a failure of therapy due to interactions between drugs that blunt or negate the intended effect. The most common contributing factor is drug interactions themselves, because when another drug or substance alters the pharmacokinetics or pharmacodynamics of the primary drug, it can drive down its levels or diminish its action, leading to subtherapeutic response or treatment failure. For example, enzyme-inducing drugs or substances can speed up metabolism and reduce drug exposure, while enzyme inhibitors can sometimes raise levels and increase toxicity, but the hallmark for Type F is the loss of efficacy from interactions with other agents. Genetic predisposition often affects whether someone experiences a particular adverse effect, but it doesn’t routinely explain therapeutic failure across patients. Dietary factors and environmental exposures can influence absorption or exposure, but they’re not the common driver of Type F ADRs.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy